Kerstin Remus
Hannover, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Long-Term Glycemic Outcomes in Pediatric Type 1 Diabetes: A 2-Year Real-World Analysis of Different Automated Insulin Delivery Systems Generations.
Journal: Diabetes technology & therapeutics
Published: September 15, 2025
In-home use of a hybrid closed loop achieves time-in-range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial.
Journal: Diabetes, obesity & metabolism
Published: February 10, 2022
Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?
Journal: Pediatric diabetes
Published: April 02, 2020
DREAM5: An open-label, randomized, cross-over study to evaluate the safety and efficacy of day and night closed-loop control by comparing the MD-Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home.
Journal: Diabetes, obesity & metabolism
Published: September 01, 2018
"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Journal: Diabetes technology & therapeutics
Published: January 19, 2017
Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes.
Journal: Pediatric diabetes
Published: September 24, 2015
Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).
Journal: Journal of diabetes research
Published: January 19, 2015
The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
Journal: Diabetes technology & therapeutics
Published: January 23, 2014
Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes.
Journal: Pediatric diabetes
Published: September 04, 2013
Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy.
Journal: Pediatric diabetes
Published: October 28, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026